Albert Labs receives preliminary acceptance of 35 novel claims for patent protected manufacturing technology

The company's proprietary manufacturing methodology, developed and validated in-house at Albert Labs' Vancouver facility, facilitates the production and scaling of highly potent yields of its KRN Active Pharmaceutical Ingredient.

Related Keywords

Vancouver ,British Columbia ,Canada ,Ali Gulamhusein ,Jean Saayman ,Chand Jagpal ,Group Albert Labs International Corp ,Albert Labs International Corp ,Inventive Claims ,Patent Protected Technology ,Albert Labs International ,Albert Labs ,